HUTCHMED (China) Ltd. (HCM)
13.76
-0.24
(-1.68%)
USD |
NASDAQ |
Nov 19, 13:06
HUTCHMED Enterprise Value : 1.556B for Nov. 18, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 18, 2026 | 1.556B |
| November 17, 2026 | 1.627B |
| November 16, 2026 | 1.685B |
| November 13, 2026 | 1.715B |
| November 12, 2026 | 1.706B |
| November 11, 2026 | 1.746B |
| November 10, 2026 | 1.798B |
| November 09, 2026 | 1.788B |
| November 06, 2026 | 1.760B |
| November 05, 2026 | 1.593B |
| November 04, 2026 | 1.544B |
| November 03, 2026 | 1.397B |
| November 02, 2026 | 1.430B |
| October 30, 2026 | 1.409B |
| October 29, 2026 | 1.486B |
| October 28, 2026 | 1.439B |
| October 27, 2026 | 1.523B |
| October 26, 2026 | 1.605B |
| October 23, 2026 | 1.621B |
| October 22, 2026 | 1.607B |
| October 21, 2026 | 1.622B |
| October 20, 2026 | 1.687B |
| October 19, 2026 | 1.589B |
| October 16, 2026 | 1.566B |
| October 15, 2026 | 1.547B |
| Date | Value |
|---|---|
| October 14, 2026 | 1.467B |
| October 13, 2026 | 1.470B |
| October 12, 2026 | 1.502B |
| October 09, 2026 | 1.575B |
| October 08, 2026 | 1.500B |
| October 07, 2026 | 1.607B |
| October 06, 2026 | 1.662B |
| October 05, 2026 | 1.612B |
| October 02, 2026 | 1.593B |
| October 01, 2026 | 1.657B |
| September 30, 2026 | 1.668B |
| September 29, 2026 | 1.584B |
| September 28, 2026 | 1.580B |
| September 25, 2026 | 1.547B |
| September 24, 2026 | 1.540B |
| September 23, 2026 | 1.622B |
| September 22, 2026 | 1.570B |
| September 21, 2026 | 1.641B |
| September 18, 2026 | 1.500B |
| September 17, 2026 | 1.526B |
| September 16, 2026 | 1.463B |
| September 15, 2026 | 1.521B |
| September 14, 2026 | 1.498B |
| September 11, 2026 | 1.352B |
| September 10, 2026 | 1.404B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| AstraZeneca PLC | 580.75B |
| GSK Plc | 124.41B |
| Sino Biopharmaceutical Ltd. | 14.33B |
| Regent Pacific Group Ltd. | -- |
| SSY Group Ltd. | -- |
Enterprise Value Related Metrics
| Earnings Yield | 0.74% |
| Normalized Earnings Yield | 1.000 |